We are looking for children aged 2 to 17 years to join a Crohn’s disease (CD) study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe IBD (including associated symptoms such as diarrhea with pus, reduced appetite, constant need to poop, weight loss and/or joint pain), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.
Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
